Promethera Announces Initiation of Phase 2b DHELIVER Study of HepaStem in Patients with Acute-on-Chronic Liver Failure (ACLF)
MONT-SAINT-GUIBERT, Belgium & TOKYO--(BUSINESS WIRE)--Jan 8, 2020--
MONT-SAINT-GUIBERT, Belgium & TOKYO--(BUSINESS WIRE)--Jan 8, 2020--